Additionally, YAP shows greater nuclear enrichment in NSCLC compared to healthy tissues [56], while elevated expression levels of YAP and TAZ have been linked to poorer survival outcomes in NSCLC patients [57]. Here, YAP1 is linked to non-small cell lung carcinoma.